Kidney cancer - Take home messages for 2024

When is urodynamic testing truly necessary, and when can it be avoided? How can clinicians make the right decision for each patient?In this episode, Prof. Enrico Finazzi Agrò (IT) is joined by Prof. Salvador Arlandis Guzmán (ES), Prof. Tufan Tarcan (TR) and Prof. Maurizio Serati ...  Show more

In this episode, UROONCO PCa associate editor Dr. Pawel Rajwa speaks with Prof. Matthew Cooperberg from the University of California about genomic and AI-based risk classifiers in localised prostate cancer and how these tools are helping to personalise patient care.They discuss h ...  Show more

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ...  Show more

<span class= "normaltextrun"><span style= "font-size: 11.0pt; line-height: 107%; font-family: 'Calibri',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-theme-font: major-fareast; mso-ansi-language: EN-US; mso-f ...

Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss promising combination therapies and other compelling advances in genitourinary cancers in advance of the 2024 ASCO Annual Meeting.

<span style= "text-decoration: underline;">TRANSCRIPT</span>